Startup Virohan, which develops educational technology for the healthcare industry, has raised $7 million in a Pre-Series B1 investment headed by Blume Ventures. Additional investors in the round included Bharat Inclusion Seed Fund, Rebright Partners, and Gesing Artha Limited. With this, the business has raised a total of $11 million.
Virohan was established in 2018 by Kunaal Dudeja, Nalin Saluja, and Archit Jayaswal as a healthcare education technology platform for Allied Health Studies (AHP). Phlebotomists, medical lab technicians, and operating room technicians are just a few of the many healthcare technician roles held by AHPs.
With the increased funding, Virohan plans to open 200+ new campuses across India, providing education to over 7,000 people. The company intends to use the fresh capital to create and distribute new training programs, expand the scope of its omnichannel training platform’s infrastructure and content into vernacular languages, and create additional features to improve students’ educational outcomes.
The company claims that it will use the funds from ALES and Rebright Partners, two of its existing backers, to grow into the Japanese market.
This funding demonstrates that investors believe in our company model’s potential for growth, social impact, and financial success. Virohan’s founder and CEO, Kunaal Dudeja, has stated that the company plans to expand internationally and train over 10,000 students in the next 18 months to meet the needs of the $100B+ global potential.
To date, Virohan has claimed to have trained students in a variety of courses with completion rates of over 96% and placement rates of over 98% within one month of the programmed duration. It collaborates with a wide range of organizations in the healthcare industry, including Fortis Escorts, 1MG, Dr. Lal Path Labs, Sarvodaya Healthcare, and Healthiness.
An estimated 35 million AHP technicians will be needed by 2028, according to a BCG-Niti Ayog assessment, and India now needs roughly 5 million. Virohan hopes to level the playing field.
By 2025, the health technology industry in India is predicted to grow to a value of $21 billion. In 2022, health tech businesses including Even, Eka Care, and Cure Bay raised capital; in FY24, the health tech industry is expected to get a similar amount of money.
From $42 Billion in 2021, Indian startups only managed to raise $25 Billion in 2022, a decrease of 40%.
Read More: Microsoft may invest $10 billion in ChatGPT